Terms: = Breast cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel
88 results:
1. Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy.
Cen Y; Chen Y; Li X; Chen X; Yu B; Yan M; Yan N; Cheng H; Li S
Biomaterials; 2024 Jul; 308():122568. PubMed ID: 38615488
[TBL] [Abstract] [Full Text] [Related]
2. rel-A/PACER/miR 7 Axis May Play a Role in Radiotherapy Treatment in breast cancer Patients.
Fazlollah S; Hossein M; Mir Davood O
Iran Biomed J; 2023 Jul; 27(4):173-82. PubMed ID: 37507347
[TBL] [Abstract] [Full Text] [Related]
3. GSH resistant, luminescent 2-(pyren-1-yl)-1
Das R; Paira P
Dalton Trans; 2023 Oct; 52(42):15365-15376. PubMed ID: 37493615
[TBL] [Abstract] [Full Text] [Related]
4. Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics.
Zubair M; Khalil S; Rasul I; Nadeem H; Noor F; Ahmad S; Alrumaihi F; Allemailem KS; Almatroudi A; Alshehri FF; Alshehri ZS
J Biomol Struct Dyn; 2023; 41(24):14715-14729. PubMed ID: 37301608
[TBL] [Abstract] [Full Text] [Related]
5. Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1.
Huang M; O'Shaughnessy J; Haiderali A; Pan W; Hu P; Chaudhuri M; Le Bailly De Tilleghem C; Cappoen N; Fasching PA
Eur J Cancer; 2022 Dec; 177():45-52. PubMed ID: 36323052
[TBL] [Abstract] [Full Text] [Related]
6. Ultrasound-guided lymph node sampling: accuracy of FNAC, end-cutting (Franseen), and side-cutting (Temno) needle biopsy techniques.
Yip SWY; Griffith JF; Chan RCK; Tong CSL; Hung EHY; Ng AWH; Lee RKL
Clin Radiol; 2022 Jun; 77(6):466-473. PubMed ID: 35410787
[TBL] [Abstract] [Full Text] [Related]
7. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.
Zhang M; Liu ZZ; Aoshima K; Cai WL; Sun H; Xu T; Zhang Y; An Y; Chen JF; Chan LH; Aoshima A; Lang SM; Tang Z; Che X; Li Y; Rutter SJ; Bossuyt V; Chen X; Morrow JS; Pusztai L; Rimm DL; Yin M; Yan Q
Sci Transl Med; 2022 Feb; 14(630):eabf5473. PubMed ID: 35108062
[TBL] [Abstract] [Full Text] [Related]
8. Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and cancer: a WHO Pharmacovigilance Database Analysis.
Dolladille C; Chrétien B; Peyro-Saint-Paul L; Alexandre J; Dejardin O; Fedrizzi S; Defer G
Neurotherapeutics; 2021 Jul; 18(3):1657-1664. PubMed ID: 34231126
[TBL] [Abstract] [Full Text] [Related]
9. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative breast cancer (TNBC) Cells.
Santolla MF; Talia M; Maggiolini M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946884
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA‑188‑5p inhibits the progression of breast cancer by targeting zinc finger protein 91.
Yang Z; Liu Z; Chang Z; Yan G
Oncol Rep; 2020 Oct; 44(4):1479-1488. PubMed ID: 32945499
[TBL] [Abstract] [Full Text] [Related]
11. breast cancer Cell Detection and Characterization from breast Milk-Derived Cells.
Bhat-Nakshatri P; Kumar B; Simpson E; Ludwig KK; Cox ML; Gao H; Liu Y; Nakshatri H
Cancer Res; 2020 Nov; 80(21):4828-4839. PubMed ID: 32934021
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in breast cancer: A Phase II Randomized Trial.
Hiller JG; Cole SW; Crone EM; Byrne DJ; Shackleford DM; Pang JB; Henderson MA; Nightingale SS; Ho KM; Myles PS; Fox S; Riedel B; Sloan EK
Clin Cancer Res; 2020 Apr; 26(8):1803-1811. PubMed ID: 31754048
[TBL] [Abstract] [Full Text] [Related]
13. Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy.
Dieckmeyer M; Ruschke S; Rohrmeier A; Syväri J; Einspieler I; Seifert-Klauss V; Schmidmayr M; Metz S; Kirschke JS; Rummeny EJ; Zimmer C; Karampinos DC; Baum T
BMC Musculoskelet Disord; 2019 Nov; 20(1):515. PubMed ID: 31694630
[TBL] [Abstract] [Full Text] [Related]
14. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
Jiang L; Ren L; Zhang X; Chen H; Chen X; Lin C; Wang L; Hou N; Pan J; Zhou Z; Huang H; Huang D; Yang J; Liang Y; Li J
EBioMedicine; 2019 May; 43():188-200. PubMed ID: 30979686
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical Expression of Microfibrillar-associated Protein 5 (MFAP5) in Invasive breast Carcinoma of No Special Type.
Dawoud MM; Abouelfadl D; Abdou AG; Elkhouly EAB
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):649-657. PubMed ID: 30320661
[TBL] [Abstract] [Full Text] [Related]
17. Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-related Cardiotoxicity in Patients with breast cancer: A Study Using 13 Years of Registry Data.
Kim EK; Cho J; Kim JY; Chang SA; Park SJ; Choi JO; Lee SC; Ahn JS; Park SW; Im YH; Jeon ES; Park YH
Cancer Res Treat; 2019 Apr; 51(2):727-736. PubMed ID: 30177584
[TBL] [Abstract] [Full Text] [Related]
18. miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-rel/CTGF signaling.
Santolla MF; Lappano R; Cirillo F; Rigiracciolo DC; Sebastiani A; Abonante S; Tassone P; Tagliaferri P; Di Martino MT; Maggiolini M; Vivacqua A
J Exp Clin Cancer Res; 2018 May; 37(1):94. PubMed ID: 29716623
[TBL] [Abstract] [Full Text] [Related]
19. Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic breast cancer: A Q-TWiST Analysis.
Cortes J; Pérez-García J; Whiting S; Wan Y; Solem C; Tai MH; Margunato-Debay S; Ko A; Fandi A; Botteman M
Clin Breast Cancer; 2018 Oct; 18(5):e919-e926. PubMed ID: 29703690
[TBL] [Abstract] [Full Text] [Related]
20. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-cancer Activity in breast (MDA-MB231) and Lung (A549) cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (rel A).
Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
[TBL] [Abstract] [Full Text] [Related]
[Next]
